2006Journal of Heze Medical CollegeRequires access

Altered Expression of C-erbB2 and P16 Gent in Gastric Carcinoma

Jianli Qu

Open publisher page 0 citations

Abstract

Objective To probe into the value of C-erbB_2 and P16 agent determining the diagnosis of carcinoma of stomach.Methods By means of immune grouped comparison,analysis has been carried out on C-erbB_2 and P16 manifestation products of carcinoma of stomach,non-typical gastric hyperplasia,gastric ulcer and normal gastric tissue slices.Results The positive incidence of C-erbB_2 of carcinoma of stomach,stomach and severe non-typical hyperplasia is obviously higher than that of the control group and gastric ulcer group.The P16 agent manifestation of carcinoma of stomach,stomach and severe non-typical hyperplasia is obviously lower than that of the control group and gastric ulcer group.Conclusion High C-erbB_2 agent manifestation and low P16 agent manifestation are both the base of molecular biochemistry and it attains great significance in testing the manifestation level of these two agents in clinical diagnosis.

About this research paper

What this paper is about

Objective To probe into the value of C-erbB_2 and P16 agent determining the diagnosis of carcinoma of stomach.Methods By means of immune grouped comparison,analysis has been carried out on C-erbB_2 and P16 manifestation products of carcinoma of stomach,non-typical gastric hyperplasia,gastric ulcer and normal gastric tissue slices.Results The positive incidence of C-erbB_2 of carcinoma of stomach,stomach and severe non-typical hyperplasia is obviously higher than that of the control group and gastric ulcer group.The P16 agent manifestation of carcinoma of stomach,stomach and severe non-typical hyperplasia is obviously lower than that of the control group and gastric ulcer group.Conclusion High C-erbB_2 agent manifestation and low P16 agent manifestation are both the base of molecular biochemistry and it attains great significance in testing the manifestation level of these two agents in clinical diagnosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To probe into the value of C-erbB_2 and P16 agent determining the diagnosis of carcinoma of stomach.Methods By means of immune grouped comparison,analysis has been carried out on C-erbB_2 and P16 manifestation products of carcinoma of stomach,non-typical gastric hyperplasia,gastric ulcer and normal gastric tissue slices.Results The positive incidence of C-erbB_2 of carcinoma of stomach,stomach and severe non-typical hyperplasia is obviously higher than that of the control group and gastric ulcer group.The P16 agent manifestation of carcinoma of stomach,stomach and severe non-typical hyperplasia is obviously lower than that of the control group and gastric ulcer group.Conclusion High C-erbB_2 agent manifestation and low P16 agent manifestation are both the base of molecular biochemistry and it attains great significance in testing the manifestation level of these two agents in clinical diagnosis.

Key concepts: Stomach, Medicine, Gastroenterology, Gastric carcinoma, Hyperplasia, Carcinoma, Internal medicine, Incidence (geometry)

Related papers

Back to paper searchBrowse research topicsOriginal source
Altered Expression of C-erbB2 and P16 Gent in Gastric Carcinoma — Research Paper | ScholarLens